Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
NCT05117567 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5868
Last updated 2021-11-11
Summary
This stepped-wedge cluster-randomized controlled trial with nested mixed methods study will assess the effectiveness, acceptability, feasibility and cost-effectiveness of a personal protection package to reduce malaria transmission among mobile and migrant populations (MMPs) and the general population in their residing villages in Lao People's Democratic Republic (PDR) and Cambodia.
Conditions
- Plasmodium Infection
Interventions
- COMBINATION_PRODUCT
-
Personal protection package
A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN), insect repellent (Icaridin), and MMP-tailored behavioural change communication (BCC) package
Sponsors & Collaborators
-
Health Poverty Action
collaborator OTHER -
Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
collaborator UNKNOWN -
National Centre for Parasitology, Entomology and Malaria Control, Cambodia
collaborator OTHER -
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
More Related Trials
-
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
NCT03783299 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia)
NCT04041973 ·Status: COMPLETED ·Phase: NA
-
Malaria Active Epidemiology and Treatment Study
NCT01280162 ·Status: COMPLETED ·Phase: NA
-
Village Malaria Worker Expansion
NCT05045547 ·Status: COMPLETED
-
Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas
NCT03916003 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
NCT00393679 ·Status: COMPLETED ·Phase: PHASE3
-
Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
NCT05041556 ·Status: RECRUITING
-
Mass Screening and Treatment for Reduction of Falciparum Malaria
NCT04093765 ·Status: COMPLETED ·Phase: NA
-
Artemisinin-resistant Malaria in Cambodia
NCT01736319 ·Status: COMPLETED
-
Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia
NCT02612545 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)
NCT03939104 ·Status: COMPLETED ·Phase: PHASE3
-
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
NCT03576313 ·Status: COMPLETED ·Phase: PHASE3
-
Malaria Genetic Surveillance in Cambodia
NCT03384472 ·Status: COMPLETED
-
Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria
NCT00519467 ·Status: COMPLETED ·Phase: PHASE2
-
PDMC Implementation Trial in Kenya
NCT06624631 ·Status: RECRUITING ·Phase: PHASE4
-
P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a)
NCT03705624 ·Status: COMPLETED ·Phase: NA
-
Mass-Drug Administration to Reduce Malaria Transmission
NCT00509015 ·Status: COMPLETED ·Phase: NA
-
Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial
NCT05764746 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand
NCT05052502 ·Status: COMPLETED ·Phase: NA
-
Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam
NCT03355664 ·Status: COMPLETED ·Phase: PHASE3
-
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
NCT02974348 ·Status: COMPLETED ·Phase: PHASE3
-
In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique
NCT05343312 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo
NCT02741024 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria
NCT05842954 ·Status: COMPLETED ·Phase: PHASE3
-
In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria
NCT02637128 ·Status: COMPLETED ·Phase: PHASE4